McKay C J, Imrie C W
Department of Surgery, Glasgow Royal Infirmary, United Kingdom.
Surg Clin North Am. 1999 Aug;79(4):733-43. doi: 10.1016/s0039-6109(05)70039-6.
Staging of acute pancreatitis is important for selection of patients for clinical trials, comparison of results between centers, and the early identification of patients who may benefit from therapeutic intervention or transfer to a specialist unit. The APACHE-II score and other multiple-factor scoring systems are widely used for the first two indications, and of these, the APACHE-II score provides the best accuracy at an early stage in the course of the illness. Presently, however, no system provides sufficient predictive power to facilitate clinical decision making. At a time of increasing pressure to involve specialist units at an early stage in the management of these complex patients, a pressing need to identify a system for accurate early staging of acute pancreatitis remains.
急性胰腺炎的分期对于临床试验患者的选择、不同中心结果的比较以及早期识别可能从治疗干预或转至专科单位中获益的患者而言至关重要。APACHE-II评分及其他多因素评分系统广泛用于前两个目的，其中，APACHE-II评分在疾病进程早期提供了最佳准确性。然而，目前尚无系统具备足够的预测能力以促进临床决策。在将专科单位尽早纳入这些复杂患者管理工作的压力不断增加的当下，准确进行急性胰腺炎早期分期系统的迫切需求依然存在。
